Skip to main content
Browse by:

Effective March 10, 2020, all Duke-sponsored events over 50 people have been cancelled, rescheduled, postponed or virtualized.
Please check with the event contact regarding event status. For more information, please see

21st Annual Duke Debates: Controversies in the Management of Patients with Hematologic Malignancies

This educational program is directed toward oncologists, hematologists, pharmacists, pharmacy technicians, nurse practitioners, physician assistants, fellows, nurses, and other health care professionals. The purpose of this conference is to educate oncologists, hematologists, and the healthcare team regarding the evolving and contemporary standards of care for the optimal treatments of patients with hematologic malignancies.

Practical issues, current standards, and controversies in the management of these diseases will be discussed in debates, traditional lectures, and tumor boards.

Topics include CAR-T and other immunotherapies used across hematologic malignancies, breast cancer, lung cancer, colon cancer, and brain tumors; debates on the management of leukemias and MPNs; debates on the management of lymphomas; and debates on the manage of sickle-cell, ADAMTS13(-) Thrombotic Microangiopathy and myeloma.

Contact: Beth Tanner